| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |